| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11906-009-0008-7 |
| P698 | PubMed publication ID | 19146799 |
| P50 | author | Steven A Claas | Q57080378 |
| Donna K Arnett | Q88878357 | ||
| P2093 | author name string | Amy I Lynch | |
| P2860 | cites work | Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans | Q28250065 |
| Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure | Q28250251 | ||
| Arterial stiffness, physical activity, and atrial natriuretic Peptide gene polymorphism in older subjects | Q28287447 | ||
| Publication bias: a brief review for clinicians | Q34111315 | ||
| The atrial natriuretic peptide gene and essential hypertension in African-Caribbeans from St Vincent and the Grenadines | Q36859292 | ||
| Atrial Natriuretic Factor and Hypertension: A Review and Metaanalysis | Q37117032 | ||
| Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. | Q37157505 | ||
| Structure and function of atrial natriuretic peptides. | Q39477370 | ||
| Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension | Q42280521 | ||
| Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro and angiotensin II-induced steroidogenesis in vivo | Q42445301 | ||
| Renin and atrial natriuretic peptide restriction fragment length polymorphisms: association with ethnicity and blood pressure | Q46210424 | ||
| Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension | Q46796559 | ||
| Polymorphisms within the atrial natriuretic peptide gene in essential hypertension | Q46891389 | ||
| Gene structure of human cardiac hormone precursor, pronatriodilatin | Q48384720 | ||
| Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. | Q48459991 | ||
| Evaluation of the atrial natriuretic peptide gene in stroke | Q48586586 | ||
| Atrial natriuretic peptide gene G664A polymorphism and the risk of ischemic cerebrovascular disease | Q48713359 | ||
| Investigation of the polymorphic ScaI site by a PCR-based assay at the human atrial natriuretic peptides (hANP) gene locus | Q50851466 | ||
| Association between polymorphisms of ACE, B2AR, ANP and ENOS and cardiovascular diseases: a community-based study in the Matsu area | Q56786483 | ||
| Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans | Q59622853 | ||
| Correspondence | Q61783487 | ||
| Heart Atria Granularity Effects of Changes in Water-Electrolyte Balance | Q66932369 | ||
| Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes | Q68426840 | ||
| Effect of atrial natriuretic factor (ANF)-related peptides on aldosterone secretion by adrenal glomerulosa cells: Critical role of the intramolecular disulphide bond | Q70221822 | ||
| Relationship of specific granules to the natriuretic and diuretic activity of rat atria | Q70478834 | ||
| Tissue fractionation studies on the relationship between an atrial natriuretic factor and specific atrial granules | Q70675980 | ||
| Atrial natriuretic peptide gene polymorphism is not associated with essential hypertension: evidence of association with ethnic origin | Q71558555 | ||
| A new polymorphic restriction site at the human atrial natriuretic peptide (hANP) gene locus | Q72084997 | ||
| Independent, marked associations of alleles of the insulin receptor and dipeptidyl carboxypeptidase-I genes with essential hypertension | Q72233810 | ||
| No effect on blood pressure level or variability of polymorphisms in DNA at the locus for atrial natriuretic factor (ANF) | Q72628950 | ||
| The gene encoding atrial natriuretic peptide and the risk of human stroke | Q73092438 | ||
| Genetic analysis of the atrial natriuretic peptide gene in essential hypertension | Q73454700 | ||
| Hpa II polymorphism of the atrial natriuretic peptide gene and the blood pressure response to salt intake in normotensive men | Q73510152 | ||
| Association study between the ANF gene and hypertension in a Gulf Arab population | Q73938285 | ||
| Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension | Q74026222 | ||
| Association study between the variants of the human ANP gene and essential hypertension | Q74030787 | ||
| [Analysis of polymorphisms Sma (Hpa II) and Sca I gene precursors of atrial natriuretic peptide (ANP) in patients with essential hypertension] | Q74621462 | ||
| Association between an atrial natriuretic peptide gene polymorphism and normal blood pressure in subjects of African ancestry | Q74651475 | ||
| [Mutation T-->C of nucleotide 2238 in the gene of atrial natriuretic peptide (ANP) precursor and heterogeneity of sodium-sensitive hypertension. Preliminary report] | Q74699293 | ||
| HpaII polymorphism in the atrial natriuretic peptide gene and hypertension | Q77795023 | ||
| [Study of genotype frequencies of ANP 664G/A polymorphism in normal subjects and CVD patients, and its association with plasma ANP levels] | Q78030406 | ||
| Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease | Q78754385 | ||
| ANP T2238C, C-664G gene polymorphism and coronary heart disease in Chinese population | Q79550058 | ||
| Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension | Q80729335 | ||
| The ScaI gene polymorphism of the atrial natriuretic factor and essential arterial hypertension in childhood | Q81309932 | ||
| Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia | Q83835656 | ||
| P433 | issue | 1 | |
| P921 | main subject | arterial hypertension | Q41861 |
| atrial natriuretic peptide | Q78185357 | ||
| P304 | page(s) | 35-42 | |
| P577 | publication date | 2009-02-01 | |
| P1433 | published in | Current Hypertension Reports | Q15746362 |
| P1476 | title | A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae | |
| P478 | volume | 11 |
| Q34452715 | A corin variant identified in hypertensive patients that alters cytoplasmic tail and reduces cell surface expression and activity |
| Q37195866 | Atrial natriuretic Peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation |
| Q42521019 | Atrial natriuretic peptide gene - a potential biomarker for long QT syndrome. |
| Q38194620 | Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases |
| Q37638257 | Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study |
| Q28082833 | Atrial natriuretic peptide in cardiovascular biology and disease (NPPA) |
| Q52638603 | Considering the vascular hypothesis for the pathogenesis of small intestinal atresia: a case control study of genetic factors. |
| Q33793053 | Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting. [Corrected] |
| Q34450973 | Distinct roles of N-glycosylation at different sites of corin in cell membrane targeting and ectodomain shedding. |
| Q47359170 | Functional analysis of corin protein domains required for PCSK6-mediated activation. |
| Q37060619 | Genetic Analysis of the Atrial Natriuretic Peptide Gene Polymorphisms among Essential Hypertensive Patients in Malaysia |
| Q38110492 | Hypertension: physiology and pathophysiology |
| Q48141874 | Identification and functional analysis of CORIN variants in hypertensive patients. |
| Q38162429 | Natriuretic peptides in cardiovascular diseases: current use and perspectives |
| Q28266080 | PCSK6-mediated corin activation is essential for normal blood pressure |
| Q54935905 | Prediction of Molecular Mechanisms for LianXia NingXin Formula: A Network Pharmacology Study. |
| Q37106593 | The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population. |
Search more.